Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec;21(1):2483018.
doi: 10.1080/21645515.2025.2483018. Epub 2025 Apr 2.

Barriers and facilitators to a combined strategy of HPV vaccination and cervical cancer screening among Mexican women

Affiliations

Barriers and facilitators to a combined strategy of HPV vaccination and cervical cancer screening among Mexican women

Leith León-Maldonado et al. Hum Vaccin Immunother. 2025 Dec.

Abstract

HPV-FASTER is an innovative public health intervention combining HPV vaccination and HPV-based screening in adult women at the same visit. FASTER-Tlalpan adapted the combined HPV-FASTER strategy in Tlalpan, Mexico City for women aged 25-45 years. To understand the barriers and facilitators to participation in a combined strategy, we conducted semi-structured interviews with 14 FASTER-Tlalpan participants. We used the constant comparative method for the analysis, as well as the socioecological model to organize the findings. At the intrapersonal level, barriers included the belief that only younger women are at risk for HPV, embarrassment about the pelvic exam, and lack of time, while facilitators were having information regarding the benefit of the combined strategy, perception of time saved by having both procedures at once, feeling reassured about their health, self-esteem regarding their health, and perceived severity of cervical cancer. Interpersonal-level barriers were experiences of stigma and prejudice, and lack of support from partners, while facilitators were family encouragement and peer-to-peer communications. Institutional-level barriers were lack of infrastructure and inconvenient hours at the health center, perceived high time burden, and low quality of care from providers, while facilitators included high-quality care by health center personnel, including partners in the combined strategy, and phone reminders. Community-level facilitators included willingness to participate. Public policy facilitators included mass information campaigns and free procedures. Our findings point to significant barriers which need to be addressed, along with facilitators which can be leveraged to scale up the combined strategy in similar settings.

Keywords: HPV vaccination; HPV-FASTER; barriers; cervical cancer; facilitators; screening; socioecological model.

PubMed Disclaimer

Conflict of interest statement

No other potential competing interest was reported by the other authors.

Figures

Figure 1.
Figure 1.
Model of women’s behavior toward a combined strategy of HPV vaccination and cervical cancer screening in Mexico.
Figure 2.
Figure 2.
Women’s perceptions of implementing a combined strategy of HPV vaccination and cervical cancer screening in Mexico.

References

    1. Franco EL, Bosch FX, Cuzick J, Schiller JT, Garnett GP, Meheus A, Wright TC.. Chapter 29: knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer. Vaccine. 2006. Aug 31;24(Suppl 3):S3/242–9. doi: 10.1016/j.vaccine.2006.06.038. - DOI - PubMed
    1. Smith JS, Brewer NT, Saslow D, Alexander K, Chernofsky MR, Crosby R, Derting L, Devlin L, Dunton CJ, Engle J, et al. Recommendations for a national agenda to substantially reduce cervical cancer. Cancer Causes Control. 2013. Aug;24(8):1583–10. doi: 10.1007/s10552-013-0235-8. - DOI - PMC - PubMed
    1. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008. Aug 19;26(Suppl10):K29–41. doi: 10.1016/j.vaccine.2008.06.019. - DOI - PubMed
    1. International Agency for Research on Cancer. World Health Organization . Global cancer observatory 2020: cancer Today. [accessed 2022 Nov 16] https://gco.iarc.fr/today/home.
    1. Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017. Feb 25;389(10071):847–860. doi: 10.1016/S0140-6736(16)31392-7. - DOI - PMC - PubMed

MeSH terms

Substances